Table 2. Risk of fracture in patients with IBD.
| Characteristics | Total No. | Fracture events | Duration (PY) | IR (per 1,000 PY) | HR (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | |||||||
| Total fracture | ||||||||||
| IBD | ||||||||||
| Control | 40,193 | 1,160 | 118,611.74 | 9.780 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 9,855 | 333 | 28,851.15 | 11.542 | 1.18 (1.04–1.33) | 1.29 (1.14–1.46) | 1.31 (1.16–1.48) | 1.31 (1.16–1.48) | ||
| CD | ||||||||||
| Control | 6,786 | 204 | 19,559.68 | 10.430 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 1,509 | 74 | 4,213.82 | 17.561 | 1.68 (1.28–2.19) | 1.93 (1.48–2.52) | 1.87 (1.43–2.44) | 1.92 (1.47–2.52) | ||
| UC | ||||||||||
| Control | 33,407 | 956 | 99,052.06 | 9.652 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 8,346 | 259 | 24,637.33 | 10.513 | 1.09 (0.95–1.25) | 1.17 (1.02–1.34) | 1.20 (1.04–1.37) | 1.19 (1.03–1.37) | ||
| Other fracture | ||||||||||
| IBD | ||||||||||
| Control | 40,193 | 612 | 118,611.74 | 5.160 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 9,855 | 155 | 28,851.15 | 5.372 | 1.04 (0.87–1.24) | 1.10 (0.93–1.32) | 1.12 (0.94–1.33) | 1.12 (0.94–1.34) | ||
| CD | ||||||||||
| Control | 6,786 | 110 | 19,559.68 | 5.624 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 1,509 | 33 | 4,213.82 | 7.831 | 1.39 (0.94–2.05) | 1.50 (1.02–2.22) | 1.49 (1.01–2.20) | 1.53 (1.03–2.28) | ||
| UC | ||||||||||
| Control | 33,407 | 502 | 99,052.06 | 5.068 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 8,346 | 122 | 24,637.33 | 4.952 | 0.98 (0.80–1.19) | 1.03 (0.84–1.25) | 1.04 (0.85–1.27) | 1.04 (0.85–1.27) | ||
| Hip fracture | ||||||||||
| IBD | ||||||||||
| Control | 40,193 | 64 | 118,611.74 | 0.540 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 9,855 | 19 | 28,851.15 | 0.659 | 1.22 (0.73–2.04) | 1.39 (0.83–2.33) | 1.43 (0.86–2.39) | 1.36 (0.81–2.28) | ||
| CD | ||||||||||
| Control | 6,786 | 12 | 19,559.68 | 0.610 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 1,509 | 3 | 4,213.82 | 0.712 | 1.16 (0.33–4.11) | 1.51 (0.42–5.41) | 1.35 (0.37–4.84) | 1.14 (0.31–4.21) | ||
| UC | ||||||||||
| Control | 33,407 | 52 | 99,052.06 | 0.525 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 8,346 | 16 | 24,637.33 | 0.649 | 1.24 (0.71–2.17) | 1.36 (0.78–2.38) | 1.41 (0.80–2.48) | 1.34 (0.76–2.37) | ||
| Vertebral fracture | ||||||||||
| IBD | ||||||||||
| Control | 40,193 | 471 | 118,611.74 | 3.971 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 9,855 | 157 | 28,851.15 | 5.441 | 1.37 (1.14–1.64) | 1.55 (1.29–1.86) | 1.58 (1.32–1.90) | 1.59(1.33–1.92) | ||
| CD | ||||||||||
| Control | 6,786 | 80 | 19,559.68 | 4.090 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 1,509 | 37 | 4,213.82 | 8.781 | 2.14 (1.45–3.15) | 2.59 (1.75–3.82) | 2.50 (1.69–3.70) | 2.60 (1.74–3.88) | ||
| UC | ||||||||||
| Control | 33,407 | 391 | 99,052.06 | 3.947 | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | 1.00 (Ref.) | ||
| Case | 8,346 | 120 | 24,637.33 | 4.871 | 1.23 (1.01–1.51) | 1.37 (1.11–1.68) | 1.41 (1.15–1.74) | 1.42 (1.15–1.75) | ||
Model 1: unadjusted analysis. Model 2: adjusted for age and sex. Model 3: adjusted for Model 2 + place of residence, income level, diabetes mellitus, hypertension, dyslipidemia and previous fracture within 5 years. Model 4: adjusted for Model 3 + body mass index, chronic kidney disease, current smoking, alcohol consumption and regular exercise.
CD = Crohn’s disease, CI = confidence interval, HR = hazard ratio, IBD = inflammatory bowel disease, IR = incidence rate, PY = person-years, Ref. = reference, UC = ulcerative colitis.